Gosset Gift of Life Biologics General Information
Gift of Life Biologics does not develop its own therapeutics but enables the development and commercialization of cell and gene therapies by supplying high-quality, GMP-compliant allogeneic cellular starting materials. The company’s assets include a large accredited donor registry, state-of-the-art processing facilities, proprietary logistics software, and full compliance with FDA Good Tissue Practices/Good Manufacturing Practices. It has established partnerships with leading biotech companies to support clinical trials globally.
Contact Information
United States
Drug Pipeline
No pipeline data available
Key Partnerships
LIfT BioSciences – preferred partner for sourcing hematopoietic stem cells for neutrophil-based immunotherapies in oncology clinical trials, Cellex – partnership to deliver customized cellular starting materials from FDA HCT/P registered & EMA GMP certified facility
Gift of Life Biologics Funding
No funding data available